about
Tailoring Biomaterials for Cancer Immunotherapy: Emerging Trends and Future Outlook.Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.Biomaterials for enhancing anti-cancer immunity.Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy.Engineering challenges for brain tumor immunotherapy.Bioengineering of Artificial Antigen Presenting Cells and Lymphoid Organs.Nanomaterials for cancer immunotherapy.Mechanically Enhanced Hierarchically Porous Scaffold Composed of Mesoporous Silica for Host Immune Cell Recruitment.
P2860
Q38677432-5BC589C9-78DC-4D7E-9019-B7DE16E5A87FQ38682486-2A79E169-2B1C-444C-BC97-C4C342A8D9F9Q38741829-021CEEF9-5172-4A52-9187-C6D43C61923DQ38756773-DD7ABE14-387C-4AF8-9930-3536A981AE4FQ39381281-57204BAB-CA0A-42EA-830F-59957D2333D9Q40044791-6BE4A8C4-BC8F-4112-B346-1B161F436560Q48646732-C29238CA-7C60-498B-BF56-68D5212A5333Q50907039-A210AD16-999E-4ACA-BAF3-3154ED2C50EF
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Engineered Materials for Cancer Immunotherapy.
@en
type
label
Engineered Materials for Cancer Immunotherapy.
@en
prefLabel
Engineered Materials for Cancer Immunotherapy.
@en
P2860
P1433
P1476
Engineered Materials for Cancer Immunotherapy
@en
P2093
David J Mooney
P2860
P304
P356
10.1016/J.NANTOD.2015.06.007
P577
2015-08-01T00:00:00Z